Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Amortization of Deferred Charges (2021 - 2025)

Biote (BTMD) has 5 years of Amortization of Deferred Charges data on record, last reported at $206000.0 in Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges rose 2.49% year-over-year to $206000.0; the TTM value through Sep 2025 reached $832000.0, up 2.97%, while the annual FY2024 figure was $819000.0, 3.15% up from the prior year.
  • Amortization of Deferred Charges reached $206000.0 in Q3 2025 per BTMD's latest filing, up from $201000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $214000.0 in Q4 2024 and bottomed at $55000.0 in Q3 2021.
  • Average Amortization of Deferred Charges over 5 years is $172411.8, with a median of $201000.0 recorded in 2024.
  • Peak YoY movement for Amortization of Deferred Charges: skyrocketed 270.91% in 2022, then dropped 1.96% in 2023.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $56000.0 in 2021, then skyrocketed by 251.79% to $197000.0 in 2022, then rose by 3.05% to $203000.0 in 2023, then rose by 5.42% to $214000.0 in 2024, then dropped by 3.74% to $206000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $206000.0 in Q3 2025, $201000.0 in Q2 2025, and $211000.0 in Q1 2025.